Omeros (NASDAQ: OMER) exec exercises options, sells stock under 10b5-1 plan
Rhea-AI Filing Summary
Omeros Corp executive David J. Borges reported an option exercise and same-day sale of common stock. On August 13, 2026, he exercised 5,000 stock options with an exercise price of $3.93 per share, acquiring 5,000 common shares, and then sold 5,000 common shares at $16.95 per share in an open-market transaction. The filing states that the sale was made under a previously established Rule 10b5-1 trading plan, and that following the option exercise, 15,000 options of this grant remained outstanding, continuing to vest in equal monthly installments from a vesting commencement date of April 1, 2022.
Positive
- None.
Negative
- None.
Insider Trade Summary 10b5-1
Exercise and Sale: 5,000 shares ($65K approx. pre-tax spread)
Exercise and Sale
3 txns
Insider
Borges David J.
Role
VP, Finance & CAO
Sold
5,000 shs ($85K)
Approx. gross sale proceeds
$85K
Approx. exercise cost
$20K
Approx. pre-tax spread
$65K
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Stock Option (Right to Buy) F2 | 5,000 | $0.00 | $0.00 |
| Exercise | Common Stock | 5,000 | $3.93 | $20K |
| Sale | Common Stock F1 | 5,000 | $16.95 | $85K |
Holdings After Transaction:
Stock Option (Right to Buy) — 15,000 shares (Direct);
Common Stock — 0 shares (Direct)
Footnotes (2)
- F1. Open market sale pursuant to a previously established Rule 10b5-1 trading plan adopted by the reporting person on February 10, 2026. The trading schedule, including sale periods and the number of shares to be sold, was established at the time of the trading plan's adoption in accordance with Rule 10b5-1 under the Securities Exchange Act of 1934, as amended.
- F2. This option vests and becomes exercisable over 48 equal monthly installments, with a vesting commencement date of April 1, 2022. Installments vest and become exercisable on each monthly anniversary thereafter.
Key Figures
Options Exercised: 5,000 shares
Option Exercise Price: $3.93 per share
Shares Sold: 5,000 shares
+5 more
8 metrics
Options Exercised
5,000 shares
Stock Option (Right to Buy) exercised on August 13, 2026
Option Exercise Price
$3.93 per share
Conversion or exercise price for stock option exercised on August 13, 2026
Shares Sold
5,000 shares
Open market sale of common stock on August 13, 2026
Sale Price
$16.95 per share
Price for 5,000 common shares sold on August 13, 2026
Options Remaining
15,000 options
Total stock options following the derivative transaction
Vesting Period
48 monthly installments
Option vests over 48 equal monthly installments from April 1, 2022
10b5-1 Plan Adoption Date
February 10, 2026
Date the Rule 10b5-1 trading plan governing the sale was adopted
Option Expiration Date
September 20, 2032
Expiration date of the stock option exercised
Key Terms
Rule 10b5-1 trading plan, Stock Option (Right to Buy), vesting commencement date, monthly anniversary
4 terms
Rule 10b5-1 trading plan regulatory
"Open market sale pursuant to a previously established Rule 10b5-1 trading plan"
A Rule 10b5-1 trading plan is a pre-arranged schedule that allows company insiders to buy or sell stock at specific times, even if they have inside information. It helps prevent accusations of unfair trading by making these transactions look planned and transparent, rather than sneaky or illegal.
Stock Option (Right to Buy) financial
"security_title: Stock Option (Right to Buy)"
vesting commencement date financial
"with a vesting commencement date of April 1, 2022"
The vesting commencement date is the starting point when an employee begins earning ownership rights to their promised benefits, such as stock options or retirement contributions. Think of it like the day a savings account is opened—only after this date do the benefits start to grow and become fully available over time. It matters to investors because it marks when the clock begins ticking toward full ownership, affecting the timing and value of these benefits.
monthly anniversary financial
"Installments vest and become exercisable on each monthly anniversary thereafter"
FAQ
What insider transactions did OMER executive David J. Borges report on August 13, 2026?
He exercised 5,000 stock options at $3.93 and acquired 5,000 common shares, then sold 5,000 shares at $16.95 the same day. The exercise and sale are reported as direct holdings.
Was the August 13, 2026 OMER stock sale by David J. Borges under a Rule 10b5-1 plan?
Yes. The filing states the 5,000-share open market sale was made pursuant to a previously established Rule 10b5-1 trading plan adopted on February 10, 2026, with the trading schedule set at that time.
How many OMER stock options remain for David J. Borges from this grant after the transaction?
After exercising 5,000 stock options, the filing reports 15,000 options of this award remaining outstanding. These options continue to vest over 48 equal monthly installments starting from April 1, 2022.
How does the Form 4 describe the vesting schedule of David J. Borges’ OMER stock options?
The option vests and becomes exercisable over 48 equal monthly installments, with a vesting commencement date of April 1, 2022. Installments vest and become exercisable on each monthly anniversary thereafter, as described in the footnote.
AI-generated analysis. How Rhea-AI works. Not financial advice.
